Clinical Trial Update: SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial comparing SU5416 to dexamethasone in progressive prostate cancer that has not responded to hormone thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• SU5416 (semaxanib)

Snippet

Sponsor: University of Chicago | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED